The Pituitary 2011
DOI: 10.1016/b978-0-12-380926-1.10008-2
|View full text |Cite
|
Sign up to set email alerts
|

The Posterior Pituitary

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 243 publications
0
8
0
Order By: Relevance
“…Neurophysin II ensures the proper targeting, packing, and storage of vasopressin and functions as a carrier protein for the neuropeptide. 22,23 The exons and introns are cleaved within the Golgi complex of vasopressin synthesizing cells, for example, in the hypothalamic supraoptic nucleus and paraventricular nucleus (PVN), where neurosecretory granules containing the cleavage products are formed. They are passed down nerve axons for storage in the posterior pituitary, where they can be released from nerve terminals into the blood stream.…”
Section: The Vasopressin Genementioning
confidence: 99%
“…Neurophysin II ensures the proper targeting, packing, and storage of vasopressin and functions as a carrier protein for the neuropeptide. 22,23 The exons and introns are cleaved within the Golgi complex of vasopressin synthesizing cells, for example, in the hypothalamic supraoptic nucleus and paraventricular nucleus (PVN), where neurosecretory granules containing the cleavage products are formed. They are passed down nerve axons for storage in the posterior pituitary, where they can be released from nerve terminals into the blood stream.…”
Section: The Vasopressin Genementioning
confidence: 99%
“…In X-linked disease, NDI is caused by mutations of the AVPR 2 gene, leading to absent signaling for AQP2 insertion into the apical membrane. It is possible to clinically possible to detect mutations in the V2R and the AQP2 genes with genetic sequencing [76]. There are 5 classes of V 2 receptor mutations leading to NDI [1,77]: (I) Abnormal mRNA that is untranslated or leads to aborted proteins (II) Translated proteins that are trapped in the endoplasmic reticulum (III) Proteins that are in the correct location but do not signal in response to ADH (IV) Proteins that are in the correct location but do not bind ADH (V) Proteins that are transported to improper organelles [77].…”
Section: Nephrogenic Diabetes Insipidus (Ndi)mentioning
confidence: 99%
“…Vasopressin (VP) is a small, COOH-terminally amidated peptide chiefly synthesized by nerve cells, hence designated as a neuropeptide. Arginine-vasopressin is the most common form in mammals, but in some species Arg is replaced by Lys see review by Bichet (14). Vasopressin is elaborated upon the processing of a larger protein precursor—preprovasopressin (15), which is packaged and processed in dense-core secretory granules that are transported to sites of release along the axon as well as the dendrites (15, 16).…”
Section: Vasopressinmentioning
confidence: 99%
“…The neurohemal interface is comprised of the median eminence and the posterior lobe of the pituitary gland also referred to as the neurohypophysis. Magnocellular neurons constitute the classic antidiuretic system that is activated by hypernatremia or hypovolemia and releases VP into the systemic circulation (14). Subsequent work has shown that the axons of magnocellular neurons also release VP en-passant in the internal zone of the median eminence (2224).…”
Section: Functional Neuroanatomy Of Vasopressinergic Neurons Of the Hmentioning
confidence: 99%